Results 81 to 90 of about 6,360 (195)

Successful Use of Difelikefalin in Severe Chronic Kidney Disease–Associated Pruritus in a Patient With Complex Etiological Contributors: A Case Report

Case Reports in Nephrology, Volume 2025, Issue 1, 2025.
Introduction: Chronic kidney disease–associated pruritus (CKD‐aP) is a frequently experienced, unpleasant skin condition. Difelikefalin, an agonist of the kappa opioid receptor, is indicated for the treatment of moderate‐to‐severe CKD‐aP in adult patients on hemodialysis.
Johannes M. Werzowa, Margit Hemetsberger, Haase-Fielitz Anja   +2 more
wiley   +1 more source

Chronic Kidney Disease With Related Oral Health Problems and Alterations in the Tongue Microbiome Illustrated by a 15‐Year‐Old Girl: A Case Report

Case Reports in Pediatrics, Volume 2025, Issue 1, 2025.
Chronic kidney disease (CKD) is characterised by a gradual loss of kidney function over time and is often linked to oral health issues. This case illustrates typical conditions in young CKD patients based on a 15‐year‐old girl with CKD stage 4 and methylmalonic aciduria, severe gingivitis and hyperplasia of the gingiva, and a need for orthodontic ...
Karolin C. Hoefer, Lutz T. Weber, Nathalie Jazmati, Michael J. Noack, Anna Greta Barbe, Isabelle Graf, Vjekoslav Krzelj   +6 more
wiley   +1 more source

The impact of sevelamer in aluminum phosphide poisoning: a preliminary study on mortality

Medicina Clínica Práctica
Background: Aluminum phosphide (ALP) poisoning, commonly referred to as rice tablet poisoning, is among the deadliest forms of poisoning. Treatment for aluminum phosphide poisoning is limited to supportive care, as no specific antidote is currently ...
Kiandokht Khorshidi, Maral Ramezani, Mitra Rahimi, Shahin Shadnia, Babak Mostafazadeh, Peyman Erfan Talab Evini   +5 more
doaj   +1 more source

Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates

Journal of Pharmacy and Bioallied Sciences, 2019
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and mortality.
Syed Arman Rabbani, Sathvik B Sridhar, Padma G M Rao, Martin T Kurian, Basset E Essawy   +4 more
doaj   +1 more source

The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: A double blind randomized clinical trial [PDF]

, 2012
Aim The majority of hemodialysis patients are hyperphosphate-mic. Hyperphosphatemia in these patients can lead to renal oste-odystrophy, vascular calcifcation, cardiovascular events, and is independently associated with mortality risk.
Aarabi, M., Baradari, A.G., Espahbodi, F., Zeydi, A.E.   +3 more
core  

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

BMC Nephrology, 2012
Background Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines.
Bleskestad Inger H, Bergrem Harald, Hartmann Anders, Godang Kristin, Gøransson Lasse G   +4 more
doaj   +1 more source

Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

International Journal of Nephrology, 2018
Background. Hyperphosphatemia in chronic kidney disease (CKD) patients is often treated with calcium carbonate (CaCO3) despite the fact that CaCO3 is associated with increased calcium load and potentially increased cardiovascular risk.
B. L. Goh, A. Soraya, A. Goh, K. L. Ang
doaj   +1 more source

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action

The Egyptian Journal of Internal Medicine, 2015
Background The non-calcium-based phosphate binder sevelamer hydrochloride was developed to provide chronic kidney disease patients with a polymer capable of managing hyperphosphatemia without an increase in the calcium load.
Bahaa Eldin Zayed, Hussein El-Fishawy, Amal R Al-Shihaby, Mohamed A Salem, Usama A.A. Sharaf El Din, Mona Mansour   +5 more
doaj   +1 more source

Calcific uraemic arteriolopathy - A mini-review [PDF]

, 2016
Calcific Uraemic Arteriolopathy (CUA) or calciphylaxis, is a thrombotic disorder of skin and subcutaneous tissue which typically presents with painful purpuric nodules that may progress to necrotic ulcers, and is a severe, life-threatening condition. CUA
Agapii, Rodica, Fragoso, Andr?, Jerónimo, Teresa, Mendes, Filipa, Neves, Pedro L, Pimentel, Ana, Rocha, Sofia Couto, Silva, Ana   +7 more
core  

2010 report of the Brazilian dialysis census [PDF]

, 2011
INTRODUCTION: National chronic dialysis data are fundamental for treatment planning. OBJECTIVE: To report data of the annual survey of the Brazilian Society of Nephrology about patients with chronic renal failure who were on dialysis in 1 July, 2010 ...
Lopes, Antonio Alberto, Lugon, Jocemir Ronaldo, Santos, Daniel Rinaldi dos, Sesso, Ricardo de Castro Cintra, Thomé, Fernando Saldanha   +4 more
core   +2 more sources